SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-09-002264
Filing Date
2009-03-02
Accepted
2009-03-05 15:14:42
Documents
12
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2190889z10-k.htm 10-K 1409607
2 EXHIBIT 10.45 a2190889zex-10_45.htm EX-10.45 859560
3 EXHIBIT 10.46 a2190889zex-10_46.htm EX-10.46 163281
4 EXHIBIT 10.47 a2190889zex-10_47.htm EX-10.47 289630
5 EX-21 a2190889zex-21.htm EX-21 3910
6 EX-23.1 a2190889zex-23_1.htm EX-23.1 2896
7 EXHIBIT 23.2 a2190889zex-23_2.htm EX-23.2 4630
8 EX-31.1 a2190889zex-31_1.htm EX-31.1 8671
9 EX-31.2 a2190889zex-31_2.htm EX-31.2 8672
10 EX-32 a2190889zex-32.htm EX-32 6170
11 G931092.JPG g931092.jpg GRAPHIC 14504
12 G975998.JPG g975998.jpg GRAPHIC 39685
  Complete submission text file 0001047469-09-002264.txt   2833571
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 09658642
SIC: 2835 In Vitro & In Vivo Diagnostic Substances